SK
Sarat Kumar Asuri
About Sarat Kumar Asuri
Data last updated:
Sarat Kumar Asuri is a Director at Synthix Global Pharma Solutions Limited (since 2025) and Cfo at Solara Active Pharma Sciences Limited (since 2025). The companies operate in Pharma. Earlier, Sarat Kumar Asuri was an Additional Director at Aurore Life Sciences Private Limited (2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Synthix Global Pharma Solutions Limited U21001MH2025PLC447046 | Director | 28 May 2025 | 2025 | Active | |
 Solara Active Pharma Sciences Limited L24230MH2017PLC291636 | Cfo | 21 Feb 2025 | 2017 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aurore Life Sciences Private Limited U74999MH2016PTC371990 | Additional Director | 13 Jan 2025 | 2016 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sarat Kumar Asuri
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sarat Kumar Asuri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sarat Kumar Asuri
Sarat Kumar Asuri currently holds 2 directorships: Synthix Global Pharma Solutions Limited (Director, since 28 May 2025); Solara Active Pharma Sciences Limited (Cfo, since 21 Feb 2025).
Sarat Kumar Asuri was first appointed on 13 Jan 2025 as Additional Director at Aurore Life Sciences Private Limited.
Sarat Kumar Asuri held 1 earlier board appointment: Aurore Life Sciences Private Limited (Additional Director, 13 Jan 2025 to 29 Sep 2025).
The current boards of Sarat Kumar Asuri's companies include Kausalya Santhanam (Synthix Global Pharma Solutions Limited), Manish Gupta (Synthix Global Pharma Solutions Limited), Mohan Muthunarayanan (Synthix Global Pharma Solutions Limited), Ramakrishnan Rajagopal (Synthix Global Pharma Solutions Limited), Ramesh (Synthix Global Pharma Solutions Limited), Venkatramani Raghavan (Synthix Global Pharma Solutions Limited), among others.